Published :
Tables : 62
Figures : 44
Category : Healthcare
No. of Pages : 210
Report Code : HC-U3264
Active Implantable Devices Market is estimated to value over USD 31.8 billion by 2027 end with a CAGR of over 6.5% during the forecast period 2020 to 2027. The increased necessity for safer, effective and faster devices is a major driving factor contributing to the growth of the market. Additionally, factors like increased number of patients diagnosed with cardiovascular diseases, rising occurrence of neurological diseases, soaring investments and financial assistance for developing advanced products and a wide range of neurostimulator applications are predicted to drive the market growth further. Furthermore, the rising geriatric population is another factor contributing to the active implantable devices market growth. However, reimbursement policies that are unfavourable to the general population shall hamper the growth of the market substantially. Market Segmentation: By Product Implantable Cardiac Pacemakers Cardioverter Defibrillators Ventricular Assist Devices Implantable Heart Monitors/Insertable Loop Recorders Neurostimulators Implantable Hearing Devices By Region North America Europe Asia-Pacific Latin America Middle East and Africa The market is categorised into product and region. The product segment is classified into implantable cardiac pacemakers, cardioverter defibrillators, ventricular assist devices, implantable heart monitors/insertable loop recorders, implantable hearing devices and neurostimulators. The implantable cardioverter defibrillators are predicted to hold the largest active implantable devices market share, and this is due to the rising prevalence of cardiovascular diseases, advancements in the development of implantable devices and increased insistence for these devices in developed nation. For instance, as per the National Institute of Health, over 50% of the deaths related to cardiovascular disorders are caused by sudden cardiac arrests and over 75% of the deaths are caused due to ventricular tachyarrhythmias. Regional Analysis: The North America region is anticipated to lead the market owing to the rising ageing population, increase in the occurrence of appalling diseases, rise in the overall healthcare expenditure and initiation of multiple projects for improving the healthcare infrastructure. The Asia Pacific region, however, is anticipated to grow at a remarkable rate during the forecasted timeframe owing to the rising geriatric population and increased preference towards fast and oily foods leading to obesity. Additionally, increased financial assistance from public and private entities for developing an efficient healthcare infrastructure has propelled the market growth in the region. Competitive Landscape: The prominent market players included are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC, Cochlear Limited, MED-EL, Sonova Holding AG, William Demant Holding A/S, Nurotron Biotechnology Co. Ltd. FutureWise Key Takeaways: Growth prospects SWOT analysis Key market trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global active implantable devices market by product and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
The increased necessity for safer, effective and faster devices is a major driving factor contributing to the growth of the market. Additionally, factors like increased number of patients diagnosed with cardiovascular diseases, rising occurrence of neurological diseases, soaring investments and financial assistance for developing advanced products and a wide range of neurostimulator applications are predicted to drive the market growth further. Furthermore, the rising geriatric population is another factor contributing to the active implantable devices market growth. However, reimbursement policies that are unfavourable to the general population shall hamper the growth of the market substantially.
Market Segmentation:
By Product
By Region
The market is categorised into product and region. The product segment is classified into implantable cardiac pacemakers, cardioverter defibrillators, ventricular assist devices, implantable heart monitors/insertable loop recorders, implantable hearing devices and neurostimulators. The implantable cardioverter defibrillators are predicted to hold the largest active implantable devices market share, and this is due to the rising prevalence of cardiovascular diseases, advancements in the development of implantable devices and increased insistence for these devices in developed nation. For instance, as per the National Institute of Health, over 50% of the deaths related to cardiovascular disorders are caused by sudden cardiac arrests and over 75% of the deaths are caused due to ventricular tachyarrhythmias.
Regional Analysis:
The North America region is anticipated to lead the market owing to the rising ageing population, increase in the occurrence of appalling diseases, rise in the overall healthcare expenditure and initiation of multiple projects for improving the healthcare infrastructure. The Asia Pacific region, however, is anticipated to grow at a remarkable rate during the forecasted timeframe owing to the rising geriatric population and increased preference towards fast and oily foods leading to obesity. Additionally, increased financial assistance from public and private entities for developing an efficient healthcare infrastructure has propelled the market growth in the region.
Competitive Landscape:
The prominent market players included are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, LivaNova PLC, Cochlear Limited, MED-EL, Sonova Holding AG, William Demant Holding A/S, Nurotron Biotechnology Co. Ltd.
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.2 Penetration and Growth Prospect Mapping 4.3 Industry Value Chain Analysis 4.4 Cost Analysis Breakdown 4.5 Technology Overview 4.6 Regulatory Framework on Country Level 4.6.1 Reimbursement Framework 4.6.2 Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1 Market Driver Analysis 5.1.2 Market Restraint Analysis 5.1.3 Industry Challenges 6. Market Analysis tools 6.1 Industry Analysis - Porter’s 6.1.1 Supplier Power 6.1.2 Buyer Power 6.1.3 Substitution Threat 6.1.4 Threat from new entrants 6.1.5 Competitive Rivalry 6.2 Pestel Analysis 6.2.1 Political Landscape 6.2.2 Environmental Landscape 6.2.3 Social landscape 6.2.4 Technology landscape 6.2.5 Legal Landscape 7. Active Implantable Devices Market, By Product Historical Analysis 2015 to 2019 and Forecast 2020-2027 (USD million) 7.1 Implantable Cardiac Pacemakers 7.2 Cardioverter Defibrillators 7.3 Ventricular Assist Devices 7.4 Implantable Heart Monitors/Insertable Loop Recorders 7.5 Neurostimulators 7.6 Implantable Hearing Devices 8. North America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 8.1. Introduction 8.2. Historical Market Size (USD Mn) Analysis By Country, 2015-2019 8.2.1. U.S. 8.2.2. Canada 8.2.3. Mexico 8.2.4. Rest of North America 8.3 Market Size (USD Mn) Forecast for North America 2020-2027 9. Latin America Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 9.1. Introduction 9.2. Regional Market Trends 9.3. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 9.3.1. Brazil 9.3.2. Uruguay 9.3.3 Argentina 9.3.4. Rest of Latin America 9.4 Market Size (US$ Mn) Forecast for Latin America 2020-2027 10. Europe Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (US$ Mn) Analysis By Country, 2015-2019 10.2.1. Germany 10.2.2. U.K 10.2.3. France 10.2.4. Italy 10.2.5 Switzerland 10.2.6. Spain 10.2.7. Russia 10.2.8. Poland 10.2.9. Rest of Western Europe 10.3 Market Size (US$ Mn) Forecast for Europe 2020-2027 11. Asia Pacific Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1 Introduction 11.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 11.2.1 Japan 11.2.2 China 11.2.3 Singapore 11.2.4 Korea 11.2.5 India 11.2.6 Australia and New Zealand 11.2.7 ASEAN 11.2.8 Rest of Asia Pacific 11.3 Market Size (US$ Mn) Forecast for Asia Pacific 2020-2027 12. Middle East and Africa Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1 Introduction 12.2 Historical Market Size (USD Mn) Analysis By Country, 2015-2019 12.2.1 UAE 12.2.2 South Africa 12.2.3 Egypt 12.2.4 Saudi Arabia 12.2.5 Rest of MEA 12.3 Market Size (US$ Mn) Forecast for MEA 2020-2027 13. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Type and Technology Portfolio, Financial Layouts) 13.1 Medtronic plc 13.1.1. Company Overview (HQ, Business Segments, Employee Strength) 13.1.2. Product Portfolio 13.1.3. SWOT Analysis 13.1.4. Financial Overview 13.1.5. Strategic Overview 13.2 Abbott Laboratories 13.2.1. Company Overview (HQ, Business Segments, Employee Strength) 13.2.2. Product Portfolio 13.2.3. SWOT Analysis 13.2.4. Financial Overview 13.2.5. Strategic Overview 13.3 Boston Scientific Corporation 13.3.1. Company Overview (HQ, Business Segments, Employee Strength) 13.3.2. Product Portfolio 13.3.3. SWOT Analysis 13.3.4. Financial Overview 13.3.5. Strategic Overview 13.4 BIOTRONIK SE & Co. KG 13.4.1. Company Overview (HQ, Business Segments, Employee Strength) 13.4.2. Product Portfolio 13.4.3. SWOT Analysis 13.4.4. Financial Overview 13.4.5. Strategic Overview 13.5 LivaNova PLC 13.5.1. Company Overview (HQ, Business Segments, Employee Strength) 13.5.2. Product Portfolio 13.5.3. SWOT Analysis 13.5.4. Financial Overview 13.5.5. Strategic Overview 13.6 Cochlear Limited 13.6.1. Company Overview (HQ, Business Segments, Employee Strength) 13.6.2. Product Portfolio 13.6.3. SWOT Analysis 13.6.4. Financial Overview 13.6.5. Strategic Overview 13.7 MED-EL 13.7.1. Company Overview (HQ, Business Segments, Employee Strength) 13.7.2. Product Portfolio 13.7.3. SWOT Analysis 13.7.4. Financial Overview 13.7.5. Strategic Overview 13.8 Sonova Holding AG 13.8.1. Company Overview (HQ, Business Segments, Employee Strength) 13.8.2. Product Portfolio 13.8.3. SWOT Analysis 13.8.4. Financial Overview 13.8.5. Strategic Overview 13.9 William Demant Holding A/S 13.9.1. Company Overview (HQ, Business Segments, Employee Strength) 13.9.2. Product Portfolio 13.9.3. SWOT Analysis 13.9.4. Financial Overview 13.9.5. Strategic Overview 13.10 Nurotron Biotechnology Co. Ltd. 13.10.1. Company Overview (HQ, Business Segments, Employee Strength) 13.10.2. Product Portfolio 13.10.3. SWOT Analysis 13.10.4. Financial Overview 13.10.5. Strategic Overview 14. Impact of COVID-19 14.1. Positive influence on the healthcare industry 14.2. The financial disruption of the manufacturing sector 14.3. Impact of COVID-19 on emerging companies 14.4. Significant mandates in the healthcare regulations initiated by administrations 14.5. The overall economic slowdown of the developing and developed nations 15. Competitive Intelligence and Competitive Matrix 15.1 Competitive Intelligence 15.2 Competitive Matrix 16. Major Deals and Strategic Alliances Analysis 16.1 Joint ventures 16.2 Mergers and acquisitions 16.3 Licensing and partnerships 16.4 Technology Collaborations 16.5 Strategic Divestments 16.6 Market Entry Strategies 17. Relevant Case Studies and Latest News Updates 18. Research Sources and List of Primary Contacts of this Study 19. Key Market Takeaway Points from the Market Analysts at Future Market Analytics
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics